France’s Tour de Force in Lung Cancer, Medscape, 23/05/2013
Barlesi F, Blons H, Beau-Faller M, et al. Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts). Program and abstracts of the American Society of Clinical Oncology Annual Meeting and Exposition; May 31-June 4, 2013; Chicago, Illinois. Abstract 8000.